- info@chironthx.com
- +1 (647) 268-7151
- 6936 Sparkling Lake Way, Ottawa, ON CANADA K4P 1R7
The Next Generation of Bio-Active Skincare
Powered by our SIST™ technology, we deliver high-potency exosomes at a scalable, commercial price point.
Exosomes are the body’s natural messengers—nanoscale vesicles that transport vital bioactive signals between cells. Unlike traditional skincare that sits on the surface, Chiron’s stem cell-derived exosomes penetrate deep into the dermis, activating the skin's natural repair mechanisms.
Powered by our proprietary SIST™ technology, we produce high-purity exosomes at an unprecedented scale, making clinical-grade regeneration accessible for premium cosmetic formulations. Our dual-approach pipeline: Aesthetic Rejuvenation and Post-Procedure Recovery—leverage our proprietary platform to deliver safe, effective, and scalable solutions, meeting the growing demand for innovative cosmetic products.
From fine lines and uneven tone to loss of firmness and glow, skin shows signs of aging, stress, and environmental damage. Chiron’s stem cell-derived exosomes offer a science-backed way to rejuvenate.
Accelerate recovery after aesthetic procedures. Our exosome formulations soothe inflammation and restore skin integrity faster than traditional serums.
Our exosomes are isolated from rigorously characterized stem cells using proprietary purification methods that preserve biological activity.
Engineered for optimal uptake and retention, Chiron exosomes deliver regenerative signals precisely where they’re needed.
Developed by scientists with deep expertise in pharmaceutical R&D, our formulations are backed by translational research and validated bioactivity.
Produced under stringent conditions that meet preclinical standards for safety and efficacy.
Our exosomes are formulated for shelf-stability without compromising biofunctionality—ideal for consumer use.
Designed by a team with experience in drug delivery and impurity profiling, ensuring consistent performance and minimal risk.
With MSC-derived exosomes from Chiron Therapeutics, skincare moves beyond surface-level cosmetics to a truly regenerative approach. Our vision is to deliver next-generation solutions for skin rejuvenation—where science, safety, and efficacy meet to unlock the skin's natural ability to heal, renew, and thrive.
Chiron Therapeutics is committed to advancing exosome-based cosmetics that are not only effective but biologically meaningful. Explore our pipelines and discover how cellular science can elevate your skincare and wound care experience.
Our cutting-edge exosome technology harnesses the power of mesenchymal stem cells to deliver regenerative signals directly to skin cells, promoting natural healing and rejuvenation at the cellular level.
Contact our team to learn more about our exosome-powered skincare and wound care solutions, or explore potential collaboration opportunities.
Dr. Behzad Yeganeh is the visionary Founder and CEO of Chiron Therapeutics, a seasoned biotech leader with over 15 years of experience translating complex biological discoveries into commercially viable assets. A two-time founder and serial entrepreneur, Dr. Yeganeh combines deep technical expertise in molecular biology with a proven track record of launching successful ventures anchored by proprietary intellectual property.
As the inventor of the revolutionary SIST technology, Dr. Yeganeh achieved a breakthrough high yield in generation of adult stem cell without genetic modification. This IP-licensed invention positions Chiron Therapeutics at the forefront of regenerative innovation, unlocking transformative therapeutic and cosmetic applications for adult stem cells.
Dr. Yeganeh’s leadership extends from bench to pre-clinical validation, including extensive experience in GMP manufacturing and regulatory strategy, notably with Health Canada. He has demonstrated a strong ability to secure non-dilutive funding and drive R&D strategies that bridge the gap between scientific innovation and market reality.